← Back to Search

Blood Flow Restriction Therapy for Achilles Tendon Injury

N/A
Recruiting
Led By Guillem Gonzalez-Lomas, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosed with Achilles Injury
Must be at least 18 years of age and younger than 65 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial will look at the effects of blood flow restriction therapy on Achilles tendon rehab.

Who is the study for?
This trial is for adults aged 18-65 with an Achilles tendon injury who plan to undergo standard physical therapy. It's not suitable for those under 18 or over 65, individuals with mental impairments, patients not opting for the study therapy, vulnerable subjects, or anyone with poor blood circulation or severe high blood pressure.Check my eligibility
What is being tested?
The study is testing Blood Flow Restriction (BFR) Therapy alongside regular physical therapy exercises to see if it helps improve strength and recovery in people rehabilitating from Achilles injuries. Participants will be randomly assigned to receive either BFR or just standard care.See study design
What are the potential side effects?
While BFR is generally safe, potential side effects may include discomfort at the restriction site, temporary numbness, bruising, and in rare cases circulatory complications.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with an Achilles injury.
Select...
I am between 18 and 65 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Measure of pain using Visual Analog Scale (VAS)
efficacy of blood flow restriction therapy on patients with Achilles injury by measure pre and post blood flow restriction therapy measured by muscle strength

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Blood flow restriction (BFR) therapyExperimental Treatment1 Intervention
Blood flow restriction therapy is a blood pressure cuff placed around the desired limb with a handheld device that controls the pressure exerted by the cuff.
Group II: Standard of Care Physical TherapyActive Control1 Intervention
Patients with Achilles injury are prescribed PT for their treatment, therefore physical therapy is a standard of care treatment for patients with tendon pathology.

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,368 Previous Clinical Trials
839,626 Total Patients Enrolled
Guillem Gonzalez-Lomas, MDPrincipal InvestigatorNew York Langone Health
3 Previous Clinical Trials
180 Total Patients Enrolled

Media Library

Blood flow restriction Clinical Trial Eligibility Overview. Trial Name: NCT04104126 — N/A
Achilles Tendon Injury Research Study Groups: Standard of Care Physical Therapy, Blood flow restriction (BFR) therapy
Achilles Tendon Injury Clinical Trial 2023: Blood flow restriction Highlights & Side Effects. Trial Name: NCT04104126 — N/A
Blood flow restriction 2023 Treatment Timeline for Medical Study. Trial Name: NCT04104126 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the approximate number of individuals who are eligible to participate in this trial?

"Affirmative. According to the clinicaltrials.gov portal, recruitment for this medical test is ongoing since its initial posting on October 8th 2021 and last update on November 23rd 2022. Specifically, 100 individuals are sought from a single site."

Answered by AI

Is there an age limitation on enrollment for this medical experiment?

"This clinical trial is available to individuals aged 18-65 who meet the requirements."

Answered by AI

What type of people is this medical trial seeking for involvement?

"A maximum of 100 individuals, 18 years and older but younger than 65 years old, with achilles tendon injuries will be admitted to this study. In order to qualify for admittance, applicants must meet the chronological requirements outlined above."

Answered by AI

Are researchers currently recruiting participants for this experiment?

"Per information on clinicaltrials.gov, this study is in the process of enrolling participants. This trial was initially posted on October 8th 2021 and has been most recently amended on November 23rd 2022."

Answered by AI
~12 spots leftby Sep 2024